Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
Posted inIOncology

ASCO GU 2025 | MCRPC Treatment Advances – Part 2

Posted by By El Bachir MOURABIT 2025.02.27Posted inIOncology0 Shares
Home » ASCO GU 2025 | MCRPC Treatment Advances – Part 2
YouTube player
Post Views: 378

Share via:

  • Facebook
  • X (Twitter)
  • LinkedIn
  • More
Last updated on 2025.02.27
El Bachir MOURABIT
View All Posts

Post navigation

Previous Post
ASCO GU 2025 | MCRPC Treatment Advances – Part 1 ASCO GU 2025 | MCRPC Treatment Advances – Part 1
Next Post
ASCO GI 2025 | Dr. Anna Dorothea Wagner：Dual-Target Therapy Shows No Survival Benefit in HER2-Positive Gastric Cancer ASCO GI 2025 | Dr. Anna Dorothea Wagner：Dual-Target Therapy Shows No Survival Benefit in HER2-Positive Gastric Cancer
  • LinkedIn
  • Twitter
  • Mail
Related Media:
Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
Media Medic Publishing Company Limited(HK)
赛美出版有限公司（香港）
Scroll to Top
  • Facebook
  • X (Twitter)
  • LinkedIn
  • More Networks
Share via
Facebook
X (Twitter)
LinkedIn
Mix
Email
Print
Copy Link
Copy link
CopyCopied